These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5574495)

  • 1. Lactose-induced discoloration of amino drugs in solid dosage form.
    Hammouda Y; Salakawy SA
    Pharmazie; 1971 Mar; 26(3):181. PubMed ID: 5574495
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-enzymic browning in solid-dosage forms: lactose-induced discoloration of neomycin tablets.
    Hammouda Y; Salakawy SA
    Pharmazie; 1971 Oct; 26(10):636-40. PubMed ID: 5149136
    [No Abstract]   [Full Text] [Related]  

  • 3. Compaction of lactose drug mixtures: quantification of the extent of incompatibility by FT-Raman spectroscopy.
    Flemming A; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Mar; 68(3):802-10. PubMed ID: 17826048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of space travel on dosage form design and use.
    Aronsohn A; Brazeau G; Hughes J
    J Gravit Physiol; 1999 Jul; 6(1):P169-72. PubMed ID: 11543006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosage form design of investigational drugs in cancer chemotherapy.
    Davignon JP
    Bull Parenter Drug Assoc; 1969; 23(2):83-9. PubMed ID: 4975731
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
    Glass BD; Haywood A
    J Pharm Pharm Sci; 2006; 9(3):398-426. PubMed ID: 17207422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on index for formulation optimization of sustained or controlled released dosage forms].
    Hong YL; Feng Y; Xu DS
    Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(1):15-7. PubMed ID: 16548158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and mechanisms in stability of drugs.
    Garrett ER
    Adv Pharm Sci; 1967; 2():1-94. PubMed ID: 4862946
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of pediatric drug formulations.
    Nahata MC
    Pediatrics; 1999 Sep; 104(3 Pt 2):607-9. PubMed ID: 10469800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid oral dosage forms.
    Helliwell M; Taylor D
    Prof Nurse; 1993 Feb; 8(5):313-7. PubMed ID: 8451252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs past their expiration date.
    Med Lett Drugs Ther; 2002 Oct; 44(1142):93-4. PubMed ID: 12403972
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms.
    Tang B; Cheng G; Gu JC; Xu CH
    Drug Discov Today; 2008 Jul; 13(13-14):606-12. PubMed ID: 18598917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
    Wu Y; Dali M; Gupta A; Raghavan K
    Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems of control of polymers used in drug technology].
    Krówczyński L
    Polim Med; 1984; 14(1-4):5-12. PubMed ID: 6533635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid form screening--a review.
    Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stability of some hydrolytic enzymes in gel form].
    Cantarella M; Ragosta G
    Boll Soc Ital Biol Sper; 1975 Sep; 51(17):1092-7. PubMed ID: 1218133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stability of polyvitaminic granulates].
    Cascioli D; Celletti P; Petrangeli B; Pullo A
    Boll Chim Farm; 1971 Jul; 110(7):408-14. PubMed ID: 5121053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stability testing of drug substances and preparations, a contribution to drug safety].
    Kny L; Stark A
    Pharmazie; 1983 Oct; 38(10):666-70. PubMed ID: 6657735
    [No Abstract]   [Full Text] [Related]  

  • 20. Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K.
    Işcan Y; Wissing SA; Hekimoğlu S; Müller RH
    Pharmazie; 2005 Dec; 60(12):905-9. PubMed ID: 16398266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.